- Home
- VCEL vs PBI Comparison
VCEL vs PBI Comparison
Compare VCEL & PBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VCEL
- PBI
- Stock Information
- Founded
- VCEL 1989
- PBI 1920
- Country
- VCEL United States
- PBI United States
- Employees
- VCEL N/A
- PBI N/A
- Industry
- VCEL Biotechnology: Biological Products (No Diagnostic Substances)
- PBI Office Equipment/Supplies/Services
- Sector
- VCEL Health Care
- PBI Miscellaneous
- Exchange
- VCEL Nasdaq
- PBI Nasdaq
- Market Cap
- VCEL 2.1B
- PBI 1.9B
- IPO Year
- VCEL 1997
- PBI N/A
- Fundamental
- Price
- VCEL $40.15
- PBI $11.48
- Analyst Decision
- VCEL Strong Buy
- PBI
- Analyst Count
- VCEL 8
- PBI 0
- Target Price
- VCEL $62.00
- PBI N/A
- AVG Volume (30 Days)
- VCEL 430.8K
- PBI 2.3M
- Earning Date
- VCEL 07-31-2025
- PBI 08-07-2025
- Dividend Yield
- VCEL N/A
- PBI 2.44%
- EPS Growth
- VCEL 521.85
- PBI N/A
- EPS
- VCEL 0.05
- PBI N/A
- Revenue
- VCEL $238,541,000.00
- PBI $1,998,749,000.00
- Revenue This Year
- VCEL $23.03
- PBI N/A
- Revenue Next Year
- VCEL $24.52
- PBI $0.40
- P/E Ratio
- VCEL $705.61
- PBI $19.85
- Revenue Growth
- VCEL 14.80
- PBI 13.20
- 52 Week Low
- VCEL $37.39
- PBI $5.58
- 52 Week High
- VCEL $63.00
- PBI $11.51
- Technical
- Relative Strength Index (RSI)
- VCEL 44.33
- PBI 72.69
- Support Level
- VCEL $40.53
- PBI $10.75
- Resistance Level
- VCEL $43.57
- PBI $11.34
- Average True Range (ATR)
- VCEL 1.62
- PBI 0.31
- MACD
- VCEL -0.16
- PBI 0.05
- Stochastic Oscillator
- VCEL 28.65
- PBI 97.79
About VCEL Vericel Corporation
Vericel Corp is a fully integrated, commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.
About PBI Pitney Bowes Inc.
Pitney Bowes Inc is a technology-driven company that provides SaaS shipping solutions, mailing innovation, and financial services to clients around the globe. The company's reportable segments are SendTech Solutions and Presort Services. SendTech Solutions includes the revenue and related expenses from physical and digital mailing and shipping technology solutions, financing, services, supplies and other applications to help simplify and save on the sending, tracking and receiving of letters, parcels and flats. Presort Services includes the revenue and related expenses from sortation services to qualify large volumes of First Class Mail, Marketing Mail and Marketing Mail Flats/Bound Printed Matter for postal worksharing discounts. It derives maximum revenue from SendTech Solutions.